Polypharmacy, therapeutic inertia, and adherence of heart recipients to drug therapy
https://doi.org/10.15825/1995-1191-2024-4-122-132
Abstract
Heart transplantation remains the gold standard treatment for end-stage heart failure. Lifelong immunosuppressive and adjuvant therapy requires constant medical follow-up in order to optimize treatment regimens and increase the adherence of heart recipients to treatment.
Objective: to study and adapt a method for systematic assessment of the complexity of treatment regimen using the MRCI index, and its link to long-term prognosis in heart recipients.
Materials and methods. Results of the study were obtained by analyzing the data of heart recipients observed at the Consultative & Diagnostic Department, Shumakov National Medical Research Center of Transplantology and Artificial Organs (Shumakov Center). The Medication Regimen Complexity Index (MRCI) was used to assess drug therapy. In our study, polypharmacy was defined as taking five or more medications, and high-risk polypharmacy was defined as the use of more than eight medications. The heart recipients were divided into two groups based on how many medications they received daily.
Results. The study included patients observed at the Consultative & Diagnostic Department, Shumakov Center from January 2008 to December 2017. The number of drugs taken by the patient at year 5 of follow-up was 9.2 ± 4.2. During the conducted data analysis, the mean total MRCI score was 48.72 ± 19.15 (from 32 to 70); medications used to treat comorbidities accounted for 42.9% of the total MRCI score, and immunosuppressive therapy accounted for 28.7%. The total MRCI score in the high-risk polypharmacy group was 58.49 ± 17.41; medications used to treat comorbidities accounted for 50.27% of the total MRCI score. The analysis revealed a correlation between the total MRCI score and the frequency of hospitalizations.
Conclusions. Patient adherence to prescribed treatment is a predictor of favorable prognosis of event-free long-term survival, but low adherence and therapeutic inertness are associated with decreased quality of life, more frequent hospitalizations and higher risk of adverse events. With proper outpatient follow-up of this patient cohort, there were no significant differences in survival in the polypharmacy and high-risk polypharmacy group.
About the Authors
I. I. MuminovRussian Federation
Moscow
A. O. Shevchenko
Russian Federation
Moscow
V. N. Poptsov
Moscow
N. N. Koloskova
Russian Federation
Nadezda Koloskova
1, Shchukinskaya str., Moscow, 123182
Phone: (926) 651-40-64
A. A. Yusova
Russian Federation
Moscow
S. A. Sakhovsky
Russian Federation
Moscow
D. D. Uvarova
Russian Federation
Moscow
References
1. Transplantology: results and prospects. Vol. XIII. 2021 / Ed. by S.V. Gautier. M.–Tver: Triada, 2022: 416.
2. Muminov II, Koloskova NN, Poptsov VN, Zakharevich VM, Mozheiko NP, Sakhovsky SA, Shevchenko AO. Experience of outpatient follow-up of heart transplant recipients at Shumakov center. Russian Journal of Transplantology and Artificial Organs. 2023; 25 (3): 68–75. https://doi.org/10.15825/1995-1191-2023-3-68-75.
3. Gautier SV, Shevchenko AO, Kormer AYa, Poptsov VN, Shevchenko OP. Prospects to improve longterm outcomes of cardiac transplantation. Russian Journal of Transplantology and Artificial Organs. 2014; 16 (3): 23–30. (In Russ.). https://doi.org/10.15825/19951191-2014-3-23-30.
4. Koloskova NN, Nikitina EA, Zakharevich VM, Muminov II, Cvan VS, Poptsov VN et al. Conversion to everolimus to preserve kidney function in a heart transplant recipient, a personalized approach of immunos uppressive therapy. Russian Journal of Transplantology and Artificial Organs. 2018; 20 (3): 70–74. (In Russ.). https://doi.org/10.15825/1995-11912018-3-70-74.
5. Wilkening GL, Brune S, Saenz PF, Vega LM, Kalich BA. Correlation between medication regimen complexity and quality of life in patients with heart failure. Res Social Adm Pharm. 2020 Oct; 16 (10): 1498–1501. doi: 10.1016/j.sapharm.2020.01.003. Epub 2020 Jan 18. PMID: 32001156.
6. George J, Phun Y-T, Bailey MJ, Kong DC, Stewart K. Development and Validation of the Medication Regimen Complexity Index. Ann Pharmacother. 2004; 38 (9): 1369–1376. doi: 10.1345/aph.1D479.
7. Hansen R, Seifeldin R, Noe L. Medication adherence in chronic disease: issues in posttransplant immunosuppression. Transplant Proc. 2007; 39: 1287–1300.
8. Abdelbary A, Kaddoura R, Balushi SA, Ahmed S, Galvez R, Ahmed A et al. Implications of the medication regimen complexity index score on hospital readmissions in elderly patients with heart failure: a retrospective cohort study. BMC Geriatr. 2023 Jun 19; 23 (1): 377. https://doi.org/10.1186/s12877-023-04062-2.
9. Harris SC, Jean SJ. Characterization of the medication regimen complexity index in high-utilizer, adult psychiatric patients. Ment Health Clin. 2020 Jul 2; 10 (4): 207–214. https://doi.org/10.9740/mhc.2020.07.207.
10. Masumoto S, Sato M, Momo K, Matsushita A, Suzuki K, Shimamura H et al. Development of medication regimen complexity index: Japanese version and application in elderly patients. Int J Clin Pharm. 2021 Aug; 43 (4): 858–863. doi: 10.1007/s11096-020-01185-z. Epub 2020 Nov 2. PMID: 33136252.
11. Clinical Recommendations «Heart Transplantation, the presence of a transplanted heart, heart graft die-off and rejection», Russian Transplant Society, approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation in 2023.
12. Sychev DA, Otdelеnov VA, Krasnova NM, Ilyina ES. Polypragmasy: A clinical pharmacologist’s view. Ter Arkh. 2016; 88 (12): 94–102. (In Russ.). doi: 10.17116/terarkh2016881294-102.
13. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017 Oct 10; 17 (1): 230. https://doi.org/10.1186/s12877-017-0621-2.
14. Gomis-Pastor M, Roig Mingell E, Mirabet Perez S, Brossa Loidi V, Lopez Lopez L, Diaz Bassons A et al. Multimorbidity and medication complexity: New challenges in heart transplantation. Clin Transplant. 2019 Oct; 33 (10): e13682. doi: 10.1111/ctr.13682. Epub 2019 Aug 28. PMID: 31368585.
15. Kamila P, Smith SG, Patzer R, Wolf MS, Marina S. Medication regimen complexity in kidney and liver transplant recipients. Transplantation. 2014 Oct 15; 98 (7): e73–e74.
16. Colavecchia AC, Putney DR, Johnson ML, Aparasu RR. Discharge medication complexity and 30-day heart failure readmissions. Res Social Adm Pharm. 2017 Jul-Aug; 13 (4): 857–863. doi: 10.1016/j.sapharm.2016.10.002. Epub 2016 Oct 8. PMID: 27771308.
Review
For citations:
Muminov I.I., Shevchenko A.O., Poptsov V.N., Koloskova N.N., Yusova A.A., Sakhovsky S.A., Uvarova D.D. Polypharmacy, therapeutic inertia, and adherence of heart recipients to drug therapy. Russian Journal of Transplantology and Artificial Organs. 2024;26(4):122-132. https://doi.org/10.15825/1995-1191-2024-4-122-132